Results 261 to 270 of about 2,760,769 (327)

Factors associated with dysfunction of autogenous arteriovenous fistula in patients with secondary hyperparathyroidism after parathyroidectomy. [PDF]

Ren Fail
Chen B, Fang Q, Tao Y, Peng S, Deng S, Yuan Y, Jiang N, Wen S, Li B, Wu Q, Zhao Z, Ge P, Li S, Lin T, Feng Z, Wen F, Fu L, Li Z, Wen J, Huang R, He C, Wang W, Ke G, Xu L, Liu S, Ma J.   +25 more
europepmc   +1 more source

Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a Pilot Randomized Clinical Trial.

Am J Nephrol
Bishop CW, Ashfaq A, Choe J, Strugnell SA, Johnson LL, Norris KC, Sprague SM.   +6 more
europepmc   +1 more source

Cardiovascular and fracture events analysis and intervention strategies in patients undergoing parathyroidectomy with secondary hyperparathyroidism. [PDF]

Gland Surg
Xu S, Xu D, Wu J, Fan J, Manyalich-Blasi M, Wang H.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Secondary Hyperparathyroidism

DeckerMed Complex General Surgical Oncology, 2019
Secondary hyperparathyroidism is defined and its pathophysiology, delineated. Key components of the diagnostic work-up, medical management, and indications for surgery are described. The operative approach and controversy on extent of parathyroidectomy are discussed. This review contains 3 figures, 1 tables, and 24 references.
Sonia L Sugg, Anna C Beck
openaire   +2 more sources

Secondary and Tertiary Hyperparathyroidism

Frontiers of Hormone Research, 2018
Secondary hyperparathyroidism (SHP) is a frequent complication of kidney diseases. At variance with all the other forms of SHP, which are compensatory conditions, renal SHP has many pathogenetic peculiarities, which have been only in part defined.
Messa, Piergiorgio, Alfieri, Carlo Maria
openaire   +5 more sources

Emerging drugs for secondary hyperparathyroidism

Expert Opinion on Emerging Drugs, 2015
Secondary hyperparathyroidism (SHPT), a common, serious, and progressive complication of chronic kidney disease (CKD), is characterized by elevated serum parathyroid hormone (PTH), parathyroid gland hyperplasia, and mineral metabolism abnormalities. These disturbances may result in CKD-mineral and bone disorder (CKD-MBD), which is associated with poor ...
M. Cozzolino, J. Tomlinson, L. Walsh, A. Bellasi   +3 more
openaire   +3 more sources

Myelofibrosis Secondary to Hyperparathyroidism [PDF]

Experimental and Clinical Endocrinology & Diabetes, 2004
We report on a young female who had presented with fatigue, bilateral knee pain and gait disturbance. Primary hyperparathyroidism was diagnosed together with splenomegaly and anemia. Bone marrow biopsy revealed myelofibrosis. A parathyroid adenoma was excised during surgical intervention.
Rumeyza Kazancioglu, Fuat Sar, Ismail Taylan, M. Agan, Baki Kumbasar, Mustafa Yenigun   +5 more
openaire   +2 more sources

Symptoms of Secondary Hyperparathyroidism in Patients Receiving Maintenance Hemodialysis: A Prospective Cohort Study.

American Journal of Kidney Diseases, 2020
RATIONALE & OBJECTIVE Although multiple lines of evidence suggest a negative impact of secondary hyperparathyroidism on patients with kidney failure treated by hemodialysis, it is uncertain whether patients can detect associated symptoms.
A. Levy, S. Xing, S. Brunelli, K. Cooper, F. Finkelstein, M. Germain, M. Kimel, R. Platt, V. Belozeroff   +8 more
semanticscholar   +1 more source